Clonidine, Depression, and Smoking Cessation
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Pharmacologic treatment of smoking is not a new idea.1However, the search for effective pharmacologic treatments for smoking has increased dramatically in the last ten years due to the realization that smoking is a dependence disorder2; that behavioral strategies are not having a large effect on the prevalence of smoking3; and that nicotine dependence is becoming more prevalent in smokers due to a selection process.4This latter process is occurring because smokers who are quitting appear to be smokers who are less dependent on nicotine. Thus, if this trend continues, in ten to 20 years the population of smokers will be almost exclusively smokers who are highly dependent on nicotine. See also page 2863. Nicotine gum was introduced in 1984 as the first proven pharmacologic aid for smoking cessation.5Encouraged by this success, other nicotine replacement therapies, eg, nicotine patch6and nicotine nasal spray,
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, persons exposed to adverse childhood experiences may benefit from using drugs such as nicotine to regulate their mood.49,52”
From Relationship of Childhood Abuse and Household Dysfunction to Many of the Leading Causes of Death in Adults (1998) · cites this paper as [52]
Citations
Cites
Clinical Pharmacology of Nicotine
Benowitz, N. L. (1986) · Annual Review of Medicine · doi:10.1146/annurev.me.37.020186.000321 · Cited by 352
Cigarette Craving, Smoking Withdrawal, and Clonidine
Glassman, A. H., Jackson, W. K., Walsh, B. T., Roose, S. P., & Rosenfeld, B. (1984) · Science · doi:10.1126/science.6387913 · Cited by 206
META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS OF NICOTINE CHEWING-GUM
Lam, W., Sacks, H., Sze, P., & Chalmers, T. (1987) · The Lancet · doi:10.1016/s0140-6736(87)93061-3 · Cited by 196
WEST, R., & SCHNEIDERS, N. (1987) · British Journal of Addiction · doi:10.1111/j.1360-0443.1987.tb01496.x · Cited by 140
Preventing relapse to cigarette smoking by behavioral skill training.
Hall, S. M., Rugg, D., Tunstall, C., & Jones, R. T. (1984) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.52.3.372 · Cited by 139
Transdermal nicotine reduces cigarette craving and nicotine preference
Rose, J. E., Herskovic, J. E., Trilling, Y., & Jarvik, M. E. (1985) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1985.203 · Cited by 119
Psychosocial stress and coping in smokers who relapse or quit.
Abrams, D. B., Monti, P. M., Pinto, R. P., & Elder, J. P. (1987) · Health Psychology · doi:10.1037//0278-6133.6.4.289 · Cited by 116
Genetics of smoking: A brief review
Hughes, J. R. (1986) · Behavior Therapy · doi:10.1016/s0005-7894(86)80066-1 · Cited by 108
Self-citationNicotine Gum to Help Stop Smoking
Hughes, J. R. (1984) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1984.03350200041018 · Cited by 99
Self-citationPrevalence of tobacco dependence and withdrawal
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.2.205 · Cited by 95
Self-citation
Cited by
Felitti, V. J., Anda, R. F., Nordenberg, D., Williamson, D. F., Spitz, A. M., Edwards, V., Koss, M. P., & Marks, J. S. (1998) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(98)00017-8 · Cited by 18,943
“Thus, persons exposed to adverse childhood experiences may benefit from using drugs such as nicotine to regulate their mood.(49,52) Consideration of the positive neuroregulatory effects of health-risk behaviors such as smoking may provide biobehavioral explanations(53) for the link between adverse childhood experience…”
BackgroundFelitti, V. J., Anda, R. F., Nordenberg, D., Williamson, D. F., Spitz, A. M., Edwards, V., Koss, M. P., & Marks, J. S. (2019) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2019.04.001 · Cited by 815
Smoking and Major Depression: A Causal Analysis
Kendler, K. S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820130038007 · Cited by 792
Major Depression and Stages of Smoking: A Longitudinal Investigation
Breslau, N., Peterson, E. L., Schultz, L. R., Chilcoat, H. D., & Andreski, P. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.2.161 · Cited by 633
“Contending explanations include (1) a causal influence of smoking on major depression, based on the possible effects of long-term nicotine exposure on neurobiologic systems that are implicated in the etiology of depression(3); and (2) the effects of shared environmental or genetic factors that predispose to both smoki…”
BackgroundNicotine Dependence and Major Depression: New Evidence From a Prospective Investigation
Breslau, N. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820130033006 · Cited by 443
Metadata
- Authors
- Hughes, J. R.
- Affiliations
- University of Vermont (US)
- Corresponding author
- Hughes, John R.
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1988-05-20
- Volume
- 259
- Issue
- 19
- Pages
- 2901
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2118886106
- Cited by
- 95
- References
- 19
- Citations by year
- 2020: 1 · 2019: 2 · 2014: 2 · 2012: 2
- FWCI
- 5.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA00109, DA-04066)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Keywords
- clonidine, smoking cessation, depression, nicotine dependence, nicotine replacement therapy, nicotine gum, nicotine patch, nicotine nasal spray
- MeSH terms
- Behavior Therapy, Clonidine, Depression, Humans, Nicotine, Smoking
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clonidine, Depression, and Smoking Cessation. https://app.cochat.ai/papers/10.1001/jama.1988.03720190069036
- The paper
- Hughes, J. R. (1988). Clonidine, Depression, and Smoking Cessation. JAMA: The Journal of the American Medical Association. https://doi.org/10.1001/jama.1988.03720190069036
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.